Top Markets
#1 DogBull DogBull +105.26%
#2 ADO Protocol ADO Protocol +63.59%
#3 Siacoin Siacoin +43.83%
#4 MarsCoin MarsCoin +38.27%
#5 UnifAI Network UnifAI Network +34.50%
#6 Useless Coin Useless Coin +30.40%
#7 Ontology Gas Ontology Gas +23.80%
#8 Magma Finance Magma Finance +22.01%
#9 Filecoin Filecoin +15.98%
#10 Apertum Apertum +13.14%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
Rang in Aktien #15970
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Aktienkurs
$15.42
Marktkapitalisierung
$320.83M
Veränderung (1 Tag)
-1.52%
Veränderung (1 Jahr)
40.67%
Land
IT
Handel Newron Pharmaceuticals S.p.A. (NP5)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Newron Pharmaceuticals S.p.A. (NP5)
Dividendenrendite (TTM) von Newron Pharmaceuticals S.p.A. (Aktienkürzel: NP5) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Newron Pharmaceuticals S.p.A. (NP5) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.48%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH